Clinical trial
TachoSil Paediatric Liver Trial (TC-019-IN)
NCT00365248 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00365248 |
|---|---|
| Title | TachoSil Paediatric Liver Trial (TC-019-IN) |
| Official title | A Prospective, Multi-centre Phase III-b Study of TachoSil in Paediatric Patients Scheduled for Resection of the Liver With or Without Segmental Liver Transplantation. |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Diseases |
| Intervention type | Drug |
| Interventions | Fibrinogen human (TachoSil) |
| Enrollment | 16 |
| Start date | Oct 1, 2005 |
| Completion | May 1, 2008 |
| First posted | Aug 17, 2006 |
| Last update posted | May 7, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: